Metabolic stress signaling
代谢应激信号
基本信息
- 批准号:9128103
- 负责人:
- 金额:$ 37.69万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2016
- 资助国家:美国
- 起止时间:2016-04-01 至 2020-03-31
- 项目状态:已结题
- 来源:
- 关键词:AccountingAchievementBeta CellBloodDataDevelopmentEnergy MetabolismFunctional disorderGene TargetingGenomicsGoalsHealthHepaticHigh Fat DietHumanHyperglycemiaInsulin ResistanceJNK-activating protein kinaseKnockout MiceKnowledgeLeadLiverMAPK8 geneMediatingMediator of activation proteinMetabolic stressMetabolic syndromeMolecularMusN-terminalNon-Insulin-Dependent Diabetes MellitusObesityPPAR alphaPathway interactionsPeripheralPhysiologicalPhysiologyProteinsRegulationRepressionResearchRoleSignal PathwaySignal TransductionSignal Transduction PathwayTestingTherapeutic InterventionTissuesbasebiological adaptation to stressdesignfeedingfibroblast growth factor 21improvedinsulin sensitivitynovel therapeuticsphosphoproteomicspreventprogramspublic health relevanceresponsetreatment strategy
项目摘要
DESCRIPTION (provided by applicant): Human obesity represents a serious world-wide health problem. One consequence of obesity is the development of metabolic syndrome, characterized by insulin resistance and hyperglycemia, that can lead to β cell dysfunction and type 2 diabetes. It is therefore important that we gain an understanding of the physiology and pathophysiology of the development of obesity because this knowledge represents a basis for the design of potential therapeutic interventions. Recent studies have identified the cJun NH2-terminal kinase (JNK) signal transduction pathway as a mediator of metabolic stress responses. Feeding a high fat diet (HFD) causes increased JNK activity and promotes both obesity and insulin resistance. Studies using tissue-specific knockout mice demonstrate a central role for JNK in the regulation of energy expenditure and the development of obesity. In contrast, JNK in peripheral tissues can cause insulin resistance without changes in obesity. The mechanism that accounts for JNK- dependent insulin resistance caused by feeding a HFD has not been defined. We have identified the PPARα pathway as a major target of hepatic JNK signaling that contributes to HFD- induced insulin resistance by regulating the expression of the hepatokine fibroblast growth factor 21 (FGF21). We have demonstrated that JNK activation caused by feeding a HFD potently suppresses PPARα activity. Consequently, disruption of hepatic JNK activity causes increased hepatic PPARα activity, increased amounts of FGF21 circulating in the blood, and improved glycemia in HFD-fed mice. Disruption of Fgf21 expression prevents the effects of JNK inhibition to cause improved glycemia. Based on these data, we propose that the PPARα/FGF21 axis mediates the effects of hepatic JNK on insulin sensitivity. The overall goal of this research program is to test the hypothesis that the PPARα/FGF21 axis contributes to metabolic stress signaling by hepatic JNK. We will examine the mechanism of JNK-mediated repression of PPARα activity. We will also test the role of the PPARα target gene Fgf21 as a mediator of JNK-regulated insulin resistance. Achievement of the goals of this proposal will increase understanding of the molecular response to obesity. We anticipate that the successful completion of this research program will lead to the identification of new mechanisms that contribute to the obesity response. This knowledge may represent a basis for the design of novel therapeutic strategies for the treatment of metabolic syndrome and type 2 diabetes.
描述(由申请人提供):人类肥胖是一个严重的世界性健康问题,其后果之一是产生以胰岛素抵抗和高血糖为特征的代谢综合征,这可能导致β细胞功能障碍和2型糖尿病。因此,我们了解肥胖发展的生理学和病理生理学非常重要,因为这些知识为设计潜在的治疗干预措施奠定了基础。最近的研究已经确定了 cJun NH2 末端激酶 (JNK) 信号转导。喂养高脂肪饮食 (HFD) 会导致 JNK 活性增加,并促进肥胖和胰岛素抵抗。使用组织特异性基因敲除小鼠的研究表明,JNK 在调节能量消耗和胰岛素抵抗中发挥着核心作用。相比之下,外周组织中的 JNK 可以导致胰岛素抵抗,而不会改变肥胖的情况。我们尚未确定 PPARα 途径是导致肥胖的主要靶点。肝JNK通过调节肝因子成纤维细胞生长因子 21 (FGF21) 的表达,有助于 HFD 诱导的胰岛素抵抗。我们已经证明,喂食 HFD 引起的 JNK 激活可有效抑制 PPARα 活性,肝脏 JNK 活性的破坏会导致肝脏功能增加。 PPARα 活性、血液中循环的 FGF21 量增加以及 HFD 喂养小鼠的血糖改善。Fgf21 表达的破坏可防止 FGF21 的影响。 JNK 抑制可改善血糖 根据这些数据,我们提出 PPARα/FGF21 轴介导肝脏 JNK 对胰岛素敏感性的影响。该研究计划的总体目标是检验 PPARα/FGF21 轴有助于的假设。我们将研究 JNK 介导的 PPARα 活性抑制机制,并测试 PPARα 靶基因 Fgf21 作为介质的作用。 JNK 调节的胰岛素抵抗。该提案目标的实现将增加对肥胖分子反应的了解。我们预计该研究计划的成功完成将有助于识别有助于肥胖反应的新机制。可能为设计用于治疗代谢性和2型糖尿病的新型治疗综合征策略奠定基础。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
Roger J Davis其他文献
Microtubule Stabilization by Bone Morphogenetic Protein Receptor-mediated Scaffolding of C-jun N- Terminal Kinase Promotes Dendrite Formation Recommended Citation
通过骨形态发生蛋白受体介导的 C-jun N 末端激酶支架实现微管稳定促进树突形成 推荐引文
- DOI:
10.1016/j.neuropharm.2019.107782 - 发表时间:
2013-06-01 - 期刊:
- 影响因子:4.7
- 作者:
Monika Podkowa;Xin Zhao;Chi;Monika Podkowa;Xin Zhao;Chi;Eleanor T Coffey;Roger J Davis;Attisano;Liliana - 通讯作者:
Liliana
Retinol-binding Protein 4 Inhibits Insulin Signaling in Adipocytes by Inducing Proinflammatory Cytokines in Macrophages through a C-jun N- Terminal Kinase-and Toll-like Receptor 4-dependent and Retinol-independent Mechanism Recommended Citation
视黄醇结合蛋白 4 通过 C-jun N 末端激酶和 Toll 样受体 4 依赖且不依赖视黄醇的机制诱导巨噬细胞中的促炎细胞因子,从而抑制脂肪细胞中的胰岛素信号转导 推荐引用
- DOI:
- 发表时间:
1970-01-01 - 期刊:
- 影响因子:0
- 作者:
Julie Norseen;Tetsuya Hosooka;A. Hammarstedt;Julie Norseen;Tetsuya Hosooka;A. Hammarstedt;M. Yore;Shashi Kant;Pratik Aryal;Urban A Kiernan;David A Phillips;H. Maruyama;Bettina J Kraus;Anny Usheva;Roger J Davis;Smith;Barbara B. Kahn - 通讯作者:
Barbara B. Kahn
Roger J Davis的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('Roger J Davis', 18)}}的其他基金
Promotion of fatty liver disease by the ASK1 pathway
ASK1 通路促进脂肪肝疾病
- 批准号:
10224186 - 财政年份:2019
- 资助金额:
$ 37.69万 - 项目类别:
Promotion of fatty liver disease by the ASK1 pathway
ASK1 通路促进脂肪肝疾病
- 批准号:
10021651 - 财政年份:2019
- 资助金额:
$ 37.69万 - 项目类别:
相似国自然基金
共和盆地东北部地区隆升剥蚀过程对干热岩形成就位的影响:来自低温热年代学的制约
- 批准号:
- 批准年份:2022
- 资助金额:30 万元
- 项目类别:青年科学基金项目
朱鹮野生种群营养生态位对繁殖成就的影响及保护对策研究
- 批准号:
- 批准年份:2022
- 资助金额:54 万元
- 项目类别:面上项目
成就目标视角下建言韧性的形成机制与作用效果研究
- 批准号:72102228
- 批准年份:2021
- 资助金额:30 万元
- 项目类别:青年科学基金项目
科研人员流动与职业成就的关系研究
- 批准号:71874049
- 批准年份:2018
- 资助金额:48.0 万元
- 项目类别:面上项目
基于目标成就评量的社区中医药健康管理服务评价及优化策略研究
- 批准号:71874047
- 批准年份:2018
- 资助金额:49.0 万元
- 项目类别:面上项目
相似海外基金
Development of Tumor and Immuno-Metabolism Based Small Molecule Therapeutics for Refractory Breast Cancer
基于肿瘤和免疫代谢的难治性乳腺癌小分子疗法的发展
- 批准号:
10266156 - 财政年份:2020
- 资助金额:
$ 37.69万 - 项目类别:
Mechanisms of pancreatic endocrine cell differentiation
胰腺内分泌细胞分化机制
- 批准号:
8853273 - 财政年份:2007
- 资助金额:
$ 37.69万 - 项目类别:
Mechanisms of pancreatic endocrine cell differentiation
胰腺内分泌细胞分化机制
- 批准号:
8703079 - 财政年份:2007
- 资助金额:
$ 37.69万 - 项目类别:
Mechanisms of pancreatic endocrine cell differentiation
胰腺内分泌细胞分化机制
- 批准号:
8584780 - 财政年份:2007
- 资助金额:
$ 37.69万 - 项目类别:
Mechanisms of pancreatic endocrine cell differentiation
胰腺内分泌细胞分化机制
- 批准号:
9095302 - 财政年份:2007
- 资助金额:
$ 37.69万 - 项目类别: